Hugo Stephenson, M.D. has been appointed president of iGuard, for Quintiles Transnational Corp., effective immediately. Dr. Stephenson will lead the company's new service that offers personalized safety information and alerts to patients taking prescription drugs. He reports to Stephen DeCherney, M.D., senior vice president and chief innovation officer.
Dr. Stephenson previously served as senior vice president of Quintiles' strategic research and safety services since 2003. Dr. Stephenson was the founder of Health Research Solutions, an Australian strategic research service provider acquired by Quintiles in 2002. He has a particular interest in strategic epidemiology and risk management, and he works closely with senior industry strategists to promote the use of strategic research activities to support advances in pharmaceutical research.
"We're capitalizing on Hugo's expertise in the area of risk management and the demand for consumer involvement in monitoring the safety of drugs that are on the market," said Dr. DeCherney.